Walk-and-talk therapy versus conventional psychotherapy for men with depressive symptoms
A randomised controlled trial is testing whether outdoor walk-and-talk therapy—combining psychological support with physical activity in natural settings—offers men with depressive symptoms greater benefit and engagement than conventional indoor psychotherapy.
Conventional psychotherapy is effective for depression but often has lower engagement and higher dropout rates among men, possibly because indoor sitting-based formats may not align with typical masculine preferences for movement and outdoor activity. This assessor-blinded, parallel-group randomised controlled trial is comparing walk-and-talk therapy (10 fortnightly 1-hour sessions of psychotherapy conducted while walking outdoors over 20 weeks) against conventional indoor therapy (same dose, sitting indoors) for men with depressive symptoms.
The primary outcome is change in overall psychological distress measured by the 21-item Depression, Anxiety and Stress Scale (DASS-21) at 5 months post-baseline. Secondary outcomes include male-type depression symptoms, mental well-being, suicidal ideation, quality of life, and cost-effectiveness. Participants are assessed at baseline, 5 months (post-intervention), and 12 months (follow-up) using linear mixed models to examine the effect of treatment group, time, and their interaction. The trial is registered and approved by the University of Newcastle Human Research Ethics Committee. A key limitation is that results are not yet available—this is a study protocol describing the design, not outcome findings. The study addresses a genuine gap: men have lower help-seeking rates and higher suicide mortality than women, and treatment formats that better suit their preferences may improve engagement.
The rationale here is practical: men are less likely to seek mental health support and dropout from conventional therapy more often, suggesting that the delivery format matters. Integrating psychotherapy with outdoor walking could address both the psychological need and the physical-activity preference simultaneously. The trial compares equal doses (10 sessions over 20 weeks) to ensure any difference reflects the modality, not treatment intensity. Secondary outcomes tracking male-specific depression presentations (e.g. irritability, anger, social withdrawal) and suicidal ideation recognise that depression in men often looks different from the textbook female presentation. Cost-effectiveness analysis will also determine whether any benefit justifies resource allocation. One caveat: outdoor settings introduce variability (weather, noise, privacy) that indoor therapy avoids, and some men may prefer confidentiality indoors. Results are expected in 2025.
The deeper explanation, the effect sizes and caveats, and what this means for your own sleep, exercise and reading — read it inside Cadence.
Open in Cadence →